Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4CAM

Structure of rat neuronal nitric oxide synthase heme domain in complex with 7-((3-Fluorophenethylamino)methyl)quinolin-2-amine

4CAM の概要
エントリーDOI10.2210/pdb4cam/pdb
関連するPDBエントリー4CAN 4CAO 4CAP 4CAQ 4CAR 4CDT 4CFT
分子名称NITRIC OXIDE SYNTHASE, BRAIN, PROTOPORPHYRIN IX CONTAINING FE, 5,6,7,8-TETRAHYDROBIOPTERIN, ... (7 entities in total)
機能のキーワードoxidoreductase, inhibitor complex
由来する生物種RATTUS NORVEGICUS (NORWAY RAT)
細胞内の位置Cell membrane, sarcolemma; Peripheral membrane protein (By similarity): P29476
タンパク質・核酸の鎖数2
化学式量合計100114.73
構造登録者
Li, H.,Poulos, T.L. (登録日: 2013-10-08, 公開日: 2014-02-19, 最終更新日: 2024-05-08)
主引用文献Cinelli, M.A.,Li, H.,Chreifi, G.,Martasek, P.,Roman, L.J.,Poulos, T.L.,Silverman, R.B.
Simplified 2-Aminoquinoline-Based Scaffold for Potent and Selective Neuronal Nitric Oxide Synthase Inhibition.
J.Med.Chem., 57:1513-, 2014
Cited by
PubMed Abstract: Since high levels of nitric oxide (NO) are implicated in neurodegenerative disorders, inhibition of the neuronal isoform of nitric oxide synthase (nNOS) and reduction of NO levels are therapeutically desirable. Nonetheless, many nNOS inhibitors mimic l-arginine and are poorly bioavailable. 2-Aminoquinoline-based scaffolds were designed with the hope that they could (a) mimic aminopyridines as potent, isoform-selective arginine isosteres and (b) possess chemical properties more conducive to oral bioavailability and CNS penetration. A series of these compounds was synthesized and assayed against purified nNOS enzymes, endothelial NOS (eNOS), and inducible NOS (iNOS). Several compounds built on a 7-substituted 2-aminoquinoline core are potent and isoform-selective; X-ray crystallography indicates that aminoquinolines exert inhibitory effects by mimicking substrate interactions with the conserved active site glutamate residue. The most potent and selective compounds, 7 and 15, were tested in a Caco-2 assay and showed good permeability and low efflux, suggesting high potential for oral bioavailability.
PubMed: 24472039
DOI: 10.1021/JM401838X
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.83 Å)
構造検証レポート
Validation report summary of 4cam
検証レポート(詳細版)ダウンロードをダウンロード

246905

件を2025-12-31に公開中

PDB statisticsPDBj update infoContact PDBjnumon